Crestline Management, L.P. 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Crestline Management, L.P. disclosed 3 US equity positions worth $58.1m in its Q3 2025 13F filing. The largest position was DNLI at 85.3% of the reported book, followed by SANA and EGHT. Against the Q2 2025 filing, it opened 0 new positions, added to 0 and reduced 2 among the top 3 holdings.
What did Crestline Management, L.P. own in Q3 2025? Top 3 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | DNLI DENALI THERAPEUTICS INC | Healthcare | 85.3% | $49.5m | 3,410,732 | -12% | reduced |
| 2 | SANA SANA BIOTECHNOLOGY INC | Healthcare | 11.1% | $6.5m | 1,820,937 | -25% | reduced |
| 3 | EGHT 8X8 INC NEW | Technology | 3.6% | $2.1m | 990,580 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.